Status:

ENROLLING_BY_INVITATION

Trajectory Study: Predicting Cardiometabolic Health in Adolescents and Young Adults Based on Childhood Fitness, Sleep, and Diet

Lead Sponsor:

Arkansas Children's Hospital Research Institute

Conditions:

Cardiometabolic Health

Eligibility:

All Genders

13-21 years

Brief Summary

The Trajectory study aims to determine whether childhood aerobic fitness, sleep quality, and diet quality predict cardiometabolic health during puberty and early adulthood, independently of adiposity.

Detailed Description

The Trajectory study is a longitudinal observational study. Participants will be recalled from two existing pediatric cohorts: the Arkansas Active Kids study (ClinicalTrials.gov ID: NCT03221673; IRB #...

Eligibility Criteria

Inclusion

  • Ages 13 to 21 years.
  • Boys or girls.
  • All ethnicities.
  • All BMIs.
  • Previous participation in the Arkansas Active Kids study and the MI Energy study.
  • Participants who previously agreed to be contacted for future research at ACNC.
  • Participants who agree to the use of their previously collected information and samples from the AAK or MI Energy studies for the follow-up study.

Exclusion

  • Asthma that requires daily use of inhalers to keep symptoms under control.
  • Asthma that requires use of rescue inhalers (e.g., albuterol) \>2 days per week.
  • Exercise-induced asthma.
  • Autism spectrum disorder (e.g., Autistic disorder, Rett disorder, Asperger disorder, childhood disintegrative disorder, pervasive developmental disorder not otherwise specified (PDD-NOS).
  • Neurological disorders (e.g. epilepsy or seizures).
  • Cancer.
  • Hormonal disease (e.g., hypothyroidism and growth hormone deficiency).
  • Autoimmune diseases (e.g., lupus, thyroiditis, juvenile idiopathic arthritis).
  • Bleeding disorders (e.g., hemophilia).
  • Chronic infections (e.g., HIV, hepatitis B, hepatitis C).
  • Other pre-existing medical conditions or medications as determined by the investigators to affect the outcomes of interest.
  • Pregnancy (verbal assessment).

Key Trial Info

Start Date :

May 20 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2029

Estimated Enrollment :

250 Patients enrolled

Trial Details

Trial ID

NCT06913985

Start Date

May 20 2025

End Date

December 31 2029

Last Update

July 2 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Arkansas Children's Hospital Research Institute

Little Rock, Arkansas, United States, 72202

2

Arkansas Children's Nutrition Center

Little Rock, Arkansas, United States, 72202